Gamida Cel

-$0.08 (-3.65%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Gamida Cel and other ETFs, options, and stocks.

About GMDA

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies.

CEO
Julian Adams
Employees
168
Headquarters
Boston, Massachusetts
Founded
1998

GMDA Key Statistics

Market cap
127.18M
Price-Earnings ratio
—
Dividend yield
—
Average volume
310.82K
High today
$2.16
Low today
$2.07
Open price
$2.16
Volume
258.95K
52 Week high
$6.84
52 Week low
$2.07

GMDA Earnings

-$0.68
-$0.55
-$0.43
-$0.30
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.34 per share
Actual
-$0.34 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure